BRCA1 in breast and ovarian cancer predisposition
- PMID: 16051027
- DOI: 10.1016/j.canlet.2004.11.006
BRCA1 in breast and ovarian cancer predisposition
Abstract
Women carrying one mutated BRCA1 allele are at increased risk of developing breast and ovarian cancer but tumor initiation requires the loss of the wild-type allele indicating that it is a tumor suppressor gene. In the 10 years since the cloning of BRCA1, a function for the gene product in the DNA damage response has been established. However, identifying the exact biochemical activities of BRCA1 has been a more difficult task. Our current understanding suggests that the molecular functions mediated by the terminal ends of BRCA1, which include an E3 ubiquitin ligase activity at the N-terminus and a protein-protein interaction surface at the C-terminus, are critical to the function of this protein in the response to DNA damage.
Similar articles
-
Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.Cancer Res. 2004 Jun 1;64(11):3790-7. doi: 10.1158/0008-5472.CAN-03-3009. Cancer Res. 2004. PMID: 15172985
-
The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5. doi: 10.1158/1055-9965.EPI-06-0562. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17301259
-
Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription.J Cell Biochem. 2003 Apr 15;88(6):1084-91. doi: 10.1002/jcb.10469. J Cell Biochem. 2003. PMID: 12647291 Review.
-
The role of p53 mutation in BRCA1-associated ovarian cancer.Minerva Ginecol. 2002 Jun;54(3):201-9. Minerva Ginecol. 2002. PMID: 12063435 Review.
-
[BRCA1 and cancer: a new lead].Bull Cancer. 2000 Oct;87(10):693-4. Bull Cancer. 2000. PMID: 11185523 French. No abstract available.
Cited by
-
Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway.Cancer Sci. 2010 Jul;101(7):1618-23. doi: 10.1111/j.1349-7006.2010.01568.x. Epub 2010 Mar 17. Cancer Sci. 2010. PMID: 20487263 Free PMC article.
-
BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells.Onco_target. 2012 Mar;3(3):299-313. doi: 10.18632/onco_target.462. Onco_target. 2012. PMID: 22431556 Free PMC article.
-
The enzymes in ubiquitin-like post-translational modifications.Biosci Trends. 2007 Aug;1(1):16-25. Biosci Trends. 2007. PMID: 20103862 Free PMC article. Review.
-
RNA polymerase III transcription in cancer: the BRF2 connection.Mol Cancer. 2011 Apr 25;10:47. doi: 10.1186/1476-4598-10-47. Mol Cancer. 2011. PMID: 21518452 Free PMC article. Review.
-
MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.Sci Rep. 2019 Jun 19;9(1):8770. doi: 10.1038/s41598-019-45165-4. Sci Rep. 2019. PMID: 31217513 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous